A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease

被引:173
作者
Tomer, Y
Concepcion, E
Greenberg, DA
机构
[1] Mt Sinai Sch Med, Div Endocrinol Diabet & Bone Dis, Dept Med, New York, NY 10029 USA
[2] Columbia Univ, Div Stat Genet, New York, NY USA
关键词
D O I
10.1089/105072502321085234
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' disease (GD) develops as a result of an interaction between susceptibility genes and environmental factors. We have previously mapped a susceptibility locus for GD on chromosome 20q11 (GD-2), which has recently been independently replicated. Among the genes mapped to 20q11 was the CD40 gene, an important costimulatory molecule and a good positional candidate gene for GD. We investigated whether the CD40 gene was the GD susceptibility gene on 20q11. Linkage analysis in a subset of Caucasian families showed a maximum multipoint logarithm of odds (LOD) score of 3.3 at the CD40 locus. We then sequenced all 9 exons of the CD40 gene in 8 probands and 10 controls and identified a new C/T single-nucleotide polymorphism (SNP) in the Kozak sequence of the CD40 gene at position -1. Case control association analysis of the CD40 C/T-1 SNP in 154 Caucasian patients with GD and 118 Caucasian controls showed an association between the CC genotype and GD (p = 0.048, relative risk [RR] = 1.6). Furthermore, the association was stronger when only the probands from the linked families (n = 20) were used (p = 0.009, RR = 4.8). Transmission disequilibrium test (TDT) analysis also showed preferential transmission of the C allele of the CD40 C/T-1 SNP to affected individuals (p = 0.02). In conclusion, our results suggested that the CD40 gene was a new susceptibility gene for GD within certain families because it was both linked and associated with GD.
引用
收藏
页码:1129 / 1135
页数:7
相关论文
共 36 条
  • [1] [Anonymous], 1996, HUM MOL GENET
  • [2] BAN Y, 2002, 84 ANN M END SOC SAN
  • [3] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [4] Brix TH, 1998, CLIN ENDOCRINOL, V48, P397
  • [5] Evidence for a major role of heredity in Graves' disease:: A population-based study of two Danish twin cohorts
    Brix, TH
    Kyvik, KO
    Christensen, K
    Hegedüs, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) : 930 - 934
  • [6] THE PRESENCE OF THYROID AUTOANTIBODIES IN CHILDREN AND ADOLESCENTS WITH AUTOIMMUNE THYROID-DISEASE AND IN THEIR SIBLINGS AND PARENTS
    BUREK, CL
    HOFFMAN, WH
    ROSE, NR
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1982, 25 (03): : 395 - 404
  • [7] Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction
    Carayanniotis, G
    Masters, SR
    Noelle, RJ
    [J]. IMMUNOLOGY, 1997, 90 (03) : 421 - 426
  • [8] DAVIES TF, 1988, ANN NY ACAD SCI, V546, P151
  • [9] THE ROLE OF CD40 IN THE REGULATION OF HUMORAL AND CELL-MEDIATED-IMMUNITY
    DURIE, FH
    FOY, TM
    MASTERS, SR
    LAMAN, JD
    NOELLE, RJ
    [J]. IMMUNOLOGY TODAY, 1994, 15 (09): : 406 - 411
  • [10] Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells
    Faure, GC
    BensoussanLejzerowicz, D
    Bene, MC
    Aubert, V
    Leclere, J
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (02): : 212 - 215